Quantifying effects of pharmacological blockers of cardiac autonomous control using variability parameters

Frontiers in Physiology

Volumn 8, Issue JAN, 2017, Pages

  Miyabara, Renata ^a,b   Berg, Karsten ^c   Kraemer, Jan F ^c   Baltatu, Ovidiu C ^a,b   Wessel, Niels ^c   Campos, Luciana A ^a,b  

^a ANHEMBI MORUMBI UNIVERSITY   (Brazil)

^b Universidade Castelo Branco   (Brazil)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Autonomic nervous system; Heart rate variability; Symbolic dynamics

Indexed keywords

HEXAMETHONIUM; METHYLATROPINE; METOPROLOL; PRAZOSIN;

ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENTROPY; EVOKED RESPONSE; HEART RATE VARIABILITY; MALE; NONHUMAN; PARASYMPATHETIC FUNCTION; PHARMACOLOGICAL BLOCKING; RAT; SENSITIVITY ANALYSIS; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE;

EID: 85011807500     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00010     Document Type: Article

References (39)

1. Baltatu, O., Fontes, M. A., Campagnole-Santos, M. J., Caligiorni, S., Ganten, D., Santos, R. A., et al. (2001). Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R428-R433.
2. Campos, L. A., Pereira, V. L. Jr., Muralikrishna, A., Albarwani, S., Brás, S., and Gouveia, S. (2013). Mathematical biomarkers for the autonomic regulation of cardiovascular system. Front. Physiol. 4:279. doi: 10.3389/fphys.2013.00279.
3. Carthy, E. R. (2014). Autonomic dysfunction in essential hypertension: a systematic review. Ann. Med. Surg. 3, 2-7. doi: 10.1016/j.amsu.2013.11.002.
4. Cerutti, C., Gustin, M. P., Paultre, C. Z., Lo, M., Julien, C., Vincent, M., et al. (1991). Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am. J. Physiol. 261, H1292-H1299.
5. Cotecchia, S., Del Vescovo, C. D., Colella, M., Caso, S., and Diviani, D. (2015). The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications. Cell. Signal. 27, 1984-1993. doi: 10.1016/j.cellsig.2015.06.009.
6. D'Elia, J. A., and Weinrauch, L. A. (2013). The autonomic nervous system and renal physiology. Int. J. Nephrol. Renovasc. Dis. 6, 149-160. doi: 10.2147/IJNRD.S40897.
7. DeQuattro, V., and Li, D. (2002). Sympatholytic therapy in primary hypertension: a user friendly role for the future. J. Hum. Hypertens. 16(Suppl. 1), S118-S123. doi: 10.1038/sj.jhh.1001356.
8. Draghici, A. E., and Taylor, J. A. (2016). The physiological basis and measurement of heart rate variability in humans. J. Physiol. Anthropol. 35, 22. doi: 10.1186/s40101-016-0113-7.
9. Farraj, A. K., Hazari, M. S., and Cascio, W. E. (2011). The utility of the small rodent electrocardiogram in toxicology. Toxicol. Sci. 121, 11-30. doi: 10.1093/toxsci/kfr021.
10. Frishman, W. H. (2008). beta-Adrenergic blockers: a 50-year historical perspective. Am. J. Ther. 15, 565-576. doi: 10.1097/MJT.0b013e318188bdca.
11. Gao, H., Welch, W. J., DiBona, G. F., and Wilcox, C. S. (1997). Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats. Am. J. Physiol. 273, H734-H739.
12. Garland, E. M., Hooper, W. B., and Robertson, D. (2013). Pure autonomic failure. Handb. Clin. Neurol. 117, 243-257. doi: 10.1016/B978-0-444-53491-0.00020-1.
13. Guzzetti, S., Borroni, E., Garbelli, P. E., Ceriani, E., Della Bella, P., Montano, N., et al. (2005). Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 112, 465-470. doi: 10.1161/CIRCULATIONAHA.104.518449.
14. Ho, Y. L., Lin, C., Lin, Y. H., and Lo, M. T. (2011). The prognostic value of non-linear analysis of heart rate variability in patients with congestive heart failure-a pilot study of multiscale entropy. PLoS ONE 6:e18699. doi: 10.1371/journal.pone.0018699.
15. Jansen, H. T., and Dellinger, J. A. (1989). Comparing the cardiac vagolytic effects of atropine and methylatropine in rhesus macaques. Pharmacol. Biochem. Behav. 32, 175-179.
16. Kurnjek, M. L., Mangiarua, E., Basso, N., and Taquini, A. C. (1983). Further studies on the development of two-kidney, two clip Goldblatt hypertension in 6-hydroxydopamine-treated rats. Hypertension 5, V3-V7.
17. Leier, C. V., Binkley, P. F., and Cody, R. J. (1990). Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure. Circulation 82, I68-I76.
18. Lewis, M. J., Short, A. L., and Lewis, K. E. (2006). Autonomic nervous system control of the cardiovascular and respiratory systems in asthma. Respir. Med. 100, 1688-1705. doi: 10.1016/j.rmed.2006.01.019.
19. Malik, M. B., Camm, T., Kleiger, A. J., Malliani, R. E., Moss, A., and Schwartz, A. J. (1996). Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043-1065.
20. Neto, O. P., Oliveira Pinheiro, A., Pereira, V. L. Jr., Pereira, R., Baltatu, O. C., and Campos, L. A. (2016). Morlet wavelet transforms of heart rate variability for autonomic nervous system activity. Appl. Comput. Harmon. Anal. 40, 200-206. doi: 10.1016/j.acha.2015.07.002.
21. Parlow, J. L., van Vlymen, J. M., and Odell, M. J. (1997). The duration of impairment of autonomic control after anticholinergic drug administration in humans. Anesth. Analg. 84, 155-159.
22. Pham, T. M., de Champlain, J., and Couture, R. (1993). Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat. Naunyn Schmiedebergs Arch. Pharmacol. 347, 42-49.
23. Poirier, L., and Tobe, S. W. (2014). Contemporary use of beta-blockers: clinical relevance of subclassification. Can. J. Cardiol. 30, S9-S15. doi: 10.1016/j.cjca.2013.12.001.
24. Pomeranz, B., Macaulay, R. J., Caudill, M. A., Kutz, I., Adam, D., Gordon, D., et al. (1985). Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 248, H151-H153.
25. Rubini, R., Porta, A., Baselli, G., Cerutti, S., and Paro, M. (1993). Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J. Auton. Nerv. Syst. 45, 181-190. doi: 10.1016/0165-1838(93)90050-5.
26. Rupreht, J., Stienstra, R., Dworacek, B., and Eggels, P. J. (1983). Methyl atropine bromide versus atropine sulphate. A clinical comparison. Acta Anaesthesiol. Belg. 34, 301-307.
27. Silva, L. E., Lataro, R. M., Castania, J. A., da Silva, C. A., Valencia, J. F., et al. (2016). Multiscale entropy analysis of heart rate variability in heart failure, hypertensive, and sinoaortic-denervated rats: classical and refined approaches. Am. J. Physiol. Regul. Integr. Comp. Physiol. 311, R150-R156. doi: 10.1152/ajpregu.00076.2016.
28. Smith, R. D., Grzelak, M. E., and Coffin, V. L. (1994). Methylatropine blocks the central effects of cholinergic antagonists. Behav. Pharmacol. 5, 167-175.
29. Stoll, H. C. (1948). Pharmacodynamic considerations of atropine and related compounds. Am. J. Med. Sci. 215, 577-592.
30. Suhrbier, A., Heringer, R., Walther, T., Malberg, H., and Wessel, N. (2006). Comparison of three methods for beat-to-beat-interval extraction from continuous blood pressure and electrocardiogram with respect to heart rate variability analysis. Biomed. Tech. 51, 70-76. doi: 10.1515/BMT.2006.013.
31. Tobaldini, E., Montano, N., Wei, S. G., Zhang, Z. H., Francis, J., Weiss, R. M., et al. (2009b). Autonomic cardiovascular modulation. IEEE Eng. Med. Biol. Magn. 28, 79-85. doi: 10.1109/MEMB.2009.934620.
32. Tobaldini, E., Porta, A., Wei, S. G., Zhang, Z. H., Francis, J., Casali, K. R., et al. (2009a). Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats. Auton. Neurosci. 150, 21-26. doi: 10.1016/j.autneu.2009.03.009.
33. Tsai, M. L., Shann, W. C., Luo, W. R., and Yen, C. T. (2004). Wavelet-based analysis of low-frequency fluctuations of blood pressure and sympathetic nerve activity in rats. Neurosci. Lett. 358, 165-168. doi: 10.1016/j.neulet.2004.01.033.
34. Voss, A., Kurths, J., Kleiner, H. J., Witt, A., Wessel, N., Saparin, P., et al. (1996). The application of methods of non-linear dynamics for the improved and predictive recognition of patients threatened by sudden cardiac death. Cardiovasc. Res. 31, 419-433.
35. Webb, R. L., Barclay, B. W., and Graybill, S. C. (1991). Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands. J. Pharmacol. Exp. Ther. 259, 1203-1212.
36. Wernicke, D., Wessel, N., Malberg, H., Plehm, R., Bauernschmitt, R., and Thierfelder, L. (2007). Autonomic cardiac control in animal models of cardiovascular diseases II. Variability analysis in transgenic rats with alpha-tropomyosin mutations Asp175Asn and Glu180Gly. Biomed. Tech. 52, 50-55. doi: 10.1515/BMT.2007.010.
37. Wessel, N., Bauernschmitt, R., Wernicke, D., Kurths, J., and Malberg, H. (2007b). Autonomic cardiac control in animal models of cardiovascular diseases. I. Methods of variability analysis. Biomed Tech. 52, 43-49. doi: 10.1515/BMT.2007.009.
38. Wessel, N., Malberg, H., Bauernschmitt, R., and Kurths, J. (2007a). Nonlinear methods of cardiovascular physics and their clinical applicability. Int. J. Bifurcat. Chaos 17, 3325-3371. doi: 10.1142/S0218127407019093.
39. Woods, R. L., Courneya, C. A., and Head, G. A. (1994). Nonuniform enhancement of baroreflex sensitivity by atrial natriuretic peptide in conscious rats and dogs. Am. J. Physiol. 267, R678-R686.